--- title: "Axsome Therapeutics Inc. 将参与富国银行医疗保健会议的炉边谈话" description: "Axsome Therapeutics Inc.是一家生物制药公司,将于 2025 年 9 月 3 日参加富国银行医疗会议。该公司定于东部时间下午 3:45 在马萨诸塞州波士顿进行一次炉边谈话。此公告最初于 2025 年 8 月 27 日通过 GlobeNewswire 发布" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/254788987.md" published_at: "2025-08-27T11:00:16.000Z" --- # Axsome Therapeutics Inc. 将参与富国银行医疗保健会议的炉边谈话 > Axsome Therapeutics Inc.是一家生物制药公司,将于 2025 年 9 月 3 日参加富国银行医疗会议。该公司定于东部时间下午 3:45 在马萨诸塞州波士顿进行一次炉边谈话。此公告最初于 2025 年 8 月 27 日通过 GlobeNewswire 发布 Axsome Therapeutics Inc.是一家专注于中枢神经系统疾病的生物制药公司,定于 2025 年 9 月 3 日参加富国银行医疗会议。该公司将在东部时间下午 3:45 于马萨诸塞州波士顿进行一次炉边谈话。免责声明:本新闻简报由公共技术公司(PUBT)使用生成性人工智能创建。虽然 PUBT 努力提供准确和及时的信息,但此 AI 生成的内容仅供参考,不应被解读为财务、投资或法律建议。Axsome Therapeutics Inc.于 2025 年 8 月 27 日通过 GlobeNewswire 发布了用于生成本新闻简报的原始内容(参考 ID:GNW9518497-en),并对此信息的内容承担全部责任。© 版权 2025 - 公共技术公司(PUBT) ### Related Stocks - [AXSM.US - Axsome Therap](https://longbridge.com/zh-CN/quote/AXSM.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Axsome Therapeutics CEO Herriot Tabuteau Reports Disposal of Common Shares | Axsome Therapeutics CEO Herriot Tabuteau has reported the disposal of common shares of the company. The full filing is a | [Link](https://longbridge.com/zh-CN/news/274570327.md) | | MoneyShow Top Picks 2026: Axsome Therapeutics Inc. (AXSM) | MoneyShow Top Picks 2026: Axsome Therapeutics Inc. (AXSM) | [Link](https://longbridge.com/zh-CN/news/273526371.md) | | Top Picks 2026: Axsome Therapeutics Inc. | Axsome Therapeutics Inc. (AXSM) is gaining attention as it has three products on the market, with significant sales grow | [Link](https://longbridge.com/zh-CN/news/273591375.md) | | Axsome Therapeutics CFO Nick Pizzie Reports Sale of Common Shares | Nick Pizzie, CFO of Axsome Therapeutics Inc., reported the sale of common shares of the company. The full filing is avai | [Link](https://longbridge.com/zh-CN/news/273565682.md) | | Axsome Therapeutics Chief Commercial Officer Ari Maizel Reports Disposal of Common Shares | Ari Maizel, Chief Commercial Officer of Axsome Therapeutics Inc., has reported the disposal of common shares of the comp | [Link](https://longbridge.com/zh-CN/news/273565677.md) | --- > **免责声明**:本文内容仅供参考,不构成任何投资建议。